Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses
- PMID: 7129644
- DOI: 10.1007/BF01666915
Concentrations of amphotericin B in faeces and blood of healthy volunteers after the oral administration of various doses
Abstract
We have investigated which dose of amphotericin B can be regarded as an optimal oral dose for the prophylaxis of colonization of the digestive tract by Candida species. Ten human volunteers were given different doses; each dose was administered for five days. The results of this study revealed that although oral doses of 0.5 g amphotericin B per day resulted in sufficient concentrations in 70% of the faecal samples obtained during application, higher doses (1.5 or 2 g per day) were required to obtain detectable amphotericin B activity in 95% and 100% of the samples, respectively. A daily dose of 1.0 g is recommended. We have taken into consideration the variation in amphotericin B concentrations among individuals following this recommended dose.
Similar articles
-
Salivary concentrations of amphotericin B following its use as an oral lozenge.Infection. 1980;8(2):63-5. doi: 10.1007/BF01639148. Infection. 1980. PMID: 6993365
-
[Amphotericin B level in feces and serum during oral administration in newborns at risk].Mycoses. 1994;37 Suppl 1:84-8. Mycoses. 1994. PMID: 7854372 Clinical Trial. German.
-
Concentrations of nystatin in faeces after oral administration of various doses of nystatin.Infection. 1979;7(4):166-70. doi: 10.1007/BF01640934. Infection. 1979. PMID: 511333
-
New dosing strategies for liposomal amphotericin B in high-risk patients.Clin Microbiol Infect. 2008 May;14 Suppl 4:55-64. doi: 10.1111/j.1469-0691.2008.01982.x. Clin Microbiol Infect. 2008. PMID: 18430130 Review.
-
Is there a therapeutic or pharmacokinetic rationale for amphotericin B dosing in systemic Candida infections?Ann Pharmacother. 1996 Jul-Aug;30(7-8):811-8. doi: 10.1177/106002809603000720. Ann Pharmacother. 1996. PMID: 8826566 Review.
Cited by
-
Synergistic enhancement of parasiticidal activity of amphotericin B using copaiba oil in nanoemulsified carrier for oral delivery: an approach for non-toxic chemotherapy.Br J Pharmacol. 2015 Jul;172(14):3596-610. doi: 10.1111/bph.13149. Epub 2015 May 19. Br J Pharmacol. 2015. PMID: 25825339 Free PMC article.
-
Clinical use of selective decontamination: the concept.Intensive Care Med. 1990;16 Suppl 3:S212-6. doi: 10.1007/BF01709703. Intensive Care Med. 1990. PMID: 2289993
-
Fungal infections in patients with neutropenia: challenges in prophylaxis and treatment.Drugs Aging. 2000 Nov;17(5):339-51. doi: 10.2165/00002512-200017050-00002. Drugs Aging. 2000. PMID: 11190415 Review.
-
Selective Intestinal Decontamination as a Method for Preventing Infectious Complications (Review).Sovrem Tekhnologii Med. 2021;12(6):86-95. doi: 10.17691/stm2020.12.6.10. Epub 2020 Dec 28. Sovrem Tekhnologii Med. 2021. PMID: 34796022 Free PMC article. Review.
-
Antifungal prophylaxis during neutropenia and immunodeficiency.Clin Microbiol Rev. 1997 Jul;10(3):477-504. doi: 10.1128/CMR.10.3.477. Clin Microbiol Rev. 1997. PMID: 9227863 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Medical